Viral Load May Be Best Biomarker For IBTs, Antiviral Advisory Cmte Suggests
Executive Summary
Viral load is probably the best available biomarker for the clinical efficacy of immune-based therapies, provided changes in plasma HIV RNA levels can be linked with a therapy's immunological benefit, FDA's Antiviral Drugs Advisory Committee suggested.